M/s Shantha Biotechnics Pvt. Ltd., Hyderabad - Technology Development Board | Department of Science & Technology

M/s Shantha Biotechnics Pvt. Ltd., Hyderabad

 

M/s Shantha Biotechnics has launched three Vaccines Hib, DPT + Hib and DPT + Hep-B + Hib. Hib is an important monovalent vaccine that has been combined with Hepatitis B and DPT vaccine to make pentavalent vaccine. The use of combination vaccines has many clear benefits like:

  • Reduced number of injections
  • Reduced exposure to thimerosal
  • Reduced number of syringes used and thus generating less vaccines related waste
  • Cost saving in transport, storage and administration and
  • Better immunization Coverage.

The company has got the WHO approval for the hepatitis B vaccine and is supplying vaccines to UN agencies in addition to the Indian market. Exim Bank has also supported the project by providing a loan of Rs. 2300 lakhs.

©2024  Technology Development Board All Rights Reserved. Website maintained by Elegant MicroWeb.